277 related articles for article (PubMed ID: 18828159)
1. High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2.
Persson F; Andrén Y; Winnes M; Wedell B; Nordkvist A; Gudnadottir G; Dahlenfors R; Sjögren H; Mark J; Stenman G
Genes Chromosomes Cancer; 2009 Jan; 48(1):69-82. PubMed ID: 18828159
[TBL] [Abstract][Full Text] [Related]
2. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
[TBL] [Abstract][Full Text] [Related]
3. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
[TBL] [Abstract][Full Text] [Related]
4. HMGA2-WIF1 Rearrangements Characterize a Distinctive Subset of Salivary Pleomorphic Adenomas With Prominent Trabecular (Canalicular Adenoma-like) Morphology.
Agaimy A; Ihrler S; Baněčková M; Costés Martineau V; Mantsopoulos K; Hartmann A; Iro H; Stoehr R; Skálová A
Am J Surg Pathol; 2022 Feb; 46(2):190-199. PubMed ID: 34324456
[TBL] [Abstract][Full Text] [Related]
5. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
6. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I
Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717
[TBL] [Abstract][Full Text] [Related]
7. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
[TBL] [Abstract][Full Text] [Related]
8. MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas.
Grünewald I; Trautmann M; Busch A; Bauer L; Huss S; Schweinshaupt P; Vollbrecht C; Odenthal M; Quaas A; Büttner R; Meyer MF; Beutner D; Hüttenbrink KB; Wardelmann E; Stenner M; Hartmann W
Oncotarget; 2016 Nov; 7(46):75261-75272. PubMed ID: 27662657
[TBL] [Abstract][Full Text] [Related]
9. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
10. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
Bahrami A; Dalton JD; Shivakumar B; Krane JF
Head Neck Pathol; 2012 Sep; 6(3):328-35. PubMed ID: 22485045
[TBL] [Abstract][Full Text] [Related]
11. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
[TBL] [Abstract][Full Text] [Related]
12. Activation of PLAG1 and HMGA2 by gene fusions involving the transcriptional regulator gene NFIB.
Afshari MK; Fehr A; Nevado PT; Andersson MK; Stenman G
Genes Chromosomes Cancer; 2020 Nov; 59(11):652-660. PubMed ID: 32654217
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.
El Hallani S; Udager AM; Bell D; Fonseca I; Thompson LDR; Assaad A; Agaimy A; Luvison AM; Miller C; Seethala RR; Chiosea S
Am J Surg Pathol; 2018 Jan; 42(1):18-27. PubMed ID: 29135520
[TBL] [Abstract][Full Text] [Related]
14. Pediatric epithelial salivary gland tumors: spectrum of histologies and cytogenetics at a children's hospital.
Craver RD; Fonseca P; Carr R
Pediatr Dev Pathol; 2010; 13(5):348-53. PubMed ID: 20055685
[TBL] [Abstract][Full Text] [Related]
15. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study.
Matsuyama A; Hisaoka M; Nagao Y; Hashimoto H
Virchows Arch; 2011 May; 458(5):583-92. PubMed ID: 21394649
[TBL] [Abstract][Full Text] [Related]
16. Metastasizing Pleomorphic Adenoma: Recurrent PLAG1/HMGA2 Rearrangements and Identification of a Novel HMGA2-TMTC2 Fusion.
Wasserman JK; Dickson BC; Smith A; Swanson D; Purgina BM; Weinreb I
Am J Surg Pathol; 2019 Aug; 43(8):1145-1151. PubMed ID: 31094927
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.
Asahina M; Saito T; Hayashi T; Fukumura Y; Mitani K; Yao T
Histopathology; 2019 Feb; 74(3):514-525. PubMed ID: 30307055
[TBL] [Abstract][Full Text] [Related]
18. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma.
Röijer E; Nordkvist A; Ström AK; Ryd W; Behrendt M; Bullerdiek J; Mark J; Stenman G
Am J Pathol; 2002 Feb; 160(2):433-40. PubMed ID: 11839563
[TBL] [Abstract][Full Text] [Related]
19. Some pleomorphic adenomas of the breast share PLAG1 rearrangements with the analogous tumour of the salivary glands.
Ma S; Zhao D; Liu Y; Rohr J; Zhang F; Ma Y; Gong L; Shi H; Wang Y; Fan L; Qin J; Wang Z; Guo S
Histopathology; 2021 Dec; 79(6):1030-1039. PubMed ID: 34292619
[TBL] [Abstract][Full Text] [Related]
20. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene.
Aström AK; Voz ML; Kas K; Röijer E; Wedell B; Mandahl N; Van de Ven W; Mark J; Stenman G
Cancer Res; 1999 Feb; 59(4):918-23. PubMed ID: 10029085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
